PAUL DONOVAN 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 17, 2009
Insider Transaction Report
Form 4
PAUL DONOVAN
SVP, Corporate Comm
Transactions
- Tax Payment
Common Stock
2009-02-12$8.80/sh−2,271$19,985→ 19,041 total - Exercise/Conversion
Common Stock
2009-02-12+6,414→ 18,835 total - Tax Payment
Common Stock
2009-02-12$8.80/sh−1,516$13,341→ 21,312 total - Exercise/Conversion
Common Stock
2009-02-12+3,993→ 22,828 total - Exercise/Conversion
Deferred Stock Units
2009-02-12−3,993→ 59,402 totalExercise: $0.00→ Common Stock (3,993 underlying) - Exercise/Conversion
Deferred Stock Units
2009-02-12−6,414→ 52,988 totalExercise: $0.00→ Common Stock (6,414 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Reflects multiple DSU awards with independent vesting schedules.